Lightbridge Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders Equity and StockBased Compensation (Details Narrative)

Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)				1 Months Ended			12 Months Ended
	Dec. 15, 2023	May 03, 2023	Dec. 15, 2022	Nov. 20, 2023	Nov. 18, 2023	Mar. 25, 2021	Dec. 31, 2023	Dec. 31, 2022
Outstanding restricted stock awards							557,688	416,316
Unrecognized compensation cost related to option awards							$ 1,300,000	$ 800,000
Common stock, shares, outstanding							13,698,274	11,900,217
Shares of common stock issued							13,698,274	11,900,217
Stock-based compensation expense							$ 3,700,000	$ 3,500,000
Total common stock and all common stock equivalents							14,209,061	12,426,120
Stock options outstanding							510,787	525,903
Description related to ATM offerings						On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company’s securities, which registration statement was declared effective on April 5, 2021 and expires on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement with the amount of the Company securities available for issuance totaling $17.9 million with $11.9 million available for future share issuances as of December 31, 2023
Available for sale Securities [Member]
Sold of ATM							1,492,148	1,855,085
Proceeds for sale of ATM							$ 6,400,000	$ 11,000,000.0
Stock issuence cost							$ 400,000	$ 500,000
2020 Equity Incentive Plan [Member]
Shares of common stock issued							1,800,000
Common stock available for future issuance							803,467
Common Share Issuances [Member]
Shares of common stock issued							13,325	10,565
Common stock issuance price range decrease							$ 4.00	$ 4.56
Common stock issuance price range increase							$ 5.82	8.35
Stock-based compensation expense							$ 60,000
Weighted average grant date fair value							$ 4.50
Restricted Stock Award Activity Member
Intrinsic fair value common stock per share							$ 3.21	$ 3.89
Fair value of the RSAs vested							$ 600,000
Unrecognized compensation cost related to restricted stock units							$ 2,600,000
Weighted-average period							2 years 1 month 6 days
2023 Transactions [Member]
Common shares issuances equity grant value				$ 1,100,000
Shares of common stock issued	58,117			266,011	41,010
Common shares equity grant price per shares				$ 3.97
Description about share compensation	96,863 of the total 290,590 RSAs that were granted on December 15, 2022 vested. These RSAs vest annually with a three-year straight line vesting period	35,088 shares were included in the total outstanding common shares at December 31, 2023 and compensation expense will be recognized straight line over the three-year vesting period			62,864 of the total 188,588 RSAs that were granted on November 18, 2021 vested. These RSAs vest annually with a three-year straight line vesting period
2022 Transactions [Member]
Common shares issuances equity grant value			$ 1,400,000
Common shares equity grant price per shares			$ 4.71
RSA Summary 2023 and 2022 [Member]
Number of restricted stock awards							557,688	416,316
Compensation expense							$ 1,200,000	$ 700,000
Two Consultants [Member]
Shares, Issued							35,482	18,852
Exercise price lower range limit							$ 1.77	$ 3.98
Fair value of the Company's common stock per share							$ 3.21	$ 3.89
Unrecognized compensation cost related to option awards							$ 41,600
Unrecognized compensation cost related to option awards vesting period							2 years
Board of Directors Chairman [Member]
Common shares issuances equity grant value			$ 200,000	$ 240,000
Common shares equity grant price per shares			$ 3.84	$ 3.97
Additional common shares			52,085	60,456
Board of Directors Chairman [Member] \| Restricted Stock Units R S A [Member]
Common shares issuances equity grant value		$ 120,000
Shares of common stock issued		35,088
Common shares equity grant price per shares		$ 3.42